ABION Inc.
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
203400 | KO
Overview
Corporate Details
- ISIN(s):
- KR7203400007
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 구로구 디지털로 242 한화비즈메트로1차 242915호, 서울특별시
- Website:
- https://abionbio.com/en/
Description
ABION Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery and development of innovative medicines, focusing on first-in-class and best-in-class therapeutics for oncology and viral diseases. The company's lead oncology asset is ABN401, a selective c-Met tyrosine kinase inhibitor (TKI) designed to treat non-small cell lung cancer (NSCLC) with MET mutations, which has shown a favorable safety profile. Another key pipeline candidate is ABN501, a novel monoclonal antibody targeting Claudin-3 for various cancers. Beyond oncology, ABION is developing ABN101, a second-generation Interferon-β formulated as a broad-spectrum anti-viral inhaler for respiratory infections. The company aims to commercialize its assets in global markets through internationally recognized clinical processes.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-08-27 00:00 |
[기재정정]투자설명서
|
Korean | 3.3 MB | ||
| 2021-08-18 00:00 |
투자설명서
|
Korean | 2.9 MB | ||
| 2021-08-02 00:00 |
[기재정정]주요사항보고서(유상증자결정)
|
Korean | 108.1 KB | ||
| 2021-08-02 00:00 |
[기재정정]증권신고서(지분증권) (2021.08)
|
Korean | 3.6 MB | ||
| 2021-07-12 00:00 |
주요사항보고서(유상증자결정)
|
Korean | 87.8 KB | ||
| 2021-07-12 00:00 |
[첨부추가]증권신고서(지분증권) (2021.08)
|
Korean | 2.8 MB | ||
| 2021-07-01 00:00 |
기타주요경영사항(자율공시)(코스닥시장 이전상장 승인)
|
Korean | 4.9 KB | ||
| 2021-06-16 00:00 |
기업설명회(IR)개최결과
|
Korean | 6.7 KB | ||
| 2021-04-28 00:00 |
이전상장결정
|
Korean | 8.5 KB | ||
| 2021-04-28 00:00 |
기타주요경영사항(자율공시)(코스닥시장 상장예비심사청구서 제출)
|
Korean | 4.1 KB | ||
| 2021-04-21 00:00 |
[기재정정]주식매수선택권부여에관한신고
|
Korean | 35.4 KB | ||
| 2021-04-21 00:00 |
[기재정정]주식매수선택권부여에관한신고
|
Korean | 39.9 KB | ||
| 2021-03-26 00:00 |
정기주주총회결과
|
Korean | 17.2 KB | ||
| 2021-03-26 00:00 |
주식매수선택권부여에관한신고
|
Korean | 13.4 KB | ||
| 2021-03-26 00:00 |
주식매수선택권부여에관한신고
|
Korean | 17.2 KB |
Automate Your Workflow. Get a real-time feed of all ABION Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for ABION Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ABION Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
